azithromycin a pharmacological agent which selectively
play

Azithromycin, a pharmacological agent which selectively inhibits - PowerPoint PPT Presentation

Azithromycin, a pharmacological agent which selectively inhibits some pathways of endocytosis: characterization, interests and mechanism of action. Donatienne Tyteca, Pharm. Thesis submitted for the dregree of Doctor in Pharmaceutical Sciences


  1. Azithromycin, a pharmacological agent which selectively inhibits some pathways of endocytosis: characterization, interests and mechanism of action. Donatienne Tyteca, Pharm. Thesis submitted for the dregree of Doctor in Pharmaceutical Sciences (PhD) Promotor: Prof. M.P. Mingeot-Leclercq Copromotors: Profs P.J. Courtoy & P.M. Tulkens Brussels, December 4 th , 2001 D. Tyteca - PhD Thesis December 4th, 2001 1

  2. Endocytosis ➥ ➥ ➥ ➥ mammalian cells take up extracellular material by a variety of mechanisms collectively termed endocytosis ➥ ➥ implications of endocytosis in physiology: ➥ ➥ ● uptake of extracellular nutrients, ● ● ● ● cellular cholesterol homeostasis, ● ● ● ● regulation of hormonal response, ● ● ● ● maintenance of cell polarity, ● ● ● ● antigen presentation, ● ● ● ● .... ● ● ● ➥ implications of endocytosis in pathology: ➥ ➥ ➥ ● ● atherosclerosis, ● ● ● ● entry of pathogens and toxins, ● ● ● ● neurogenerative diseases (Alzheimer, prion), ● ● ● ● .... ● ● (Mukherjee et al, 1997) D. Tyteca - PhD Thesis December 4th, 2001 2

  3. Pathways of endocytosis studied in this thesis pinocytosis phagocytosis zipper non-coated trigger coated pit pit recycling compartment early phagosome sorting endosome late late phagosome endosome D. Tyteca - PhD Thesis December 4th, 2001 lysosome 3

  4. Membrane lipids are implicated at various stages of the endocytic process membrane organization in domains membrane asymmetry membrane fluidity D. Tyteca - PhD Thesis December 4th, 2001 4

  5. Molecular machineries of endocytic pathways membrane coat proteins: cytoskeleton adhesion to a budding tension and clathrin, APs curved particle asymmetry COPs fission dynamin transport actin microtubules docking fusion Rab SNARE/SNAP PI 3-kinase membrane acidification H + H + vacuolar H + H + H + -ATPase D. Tyteca - PhD Thesis December 4th, 2001 5

  6. What is the place of pharmacological inhibitors to dissect the endocytic apparatus ? Conditions, mutations and agents have been extensively used to dissect cellular mechanisms of endocytosis: ➥ ➥ ➥ ➥ conditions: ● K+ depletion (Cupers et al, 1994) ● ● ● ● incubation in hypertonic medium (Cupers et al, 1994; 1997) ● ● ● ● cytosol acidification (Sandvig et al, 1987) ● ● ● ➥ ➥ mutants: ➥ ➥ ● clathrin, adaptor proteins and associated proteins ● ● ● ● COP ● ● ● ● dynamin ● ● ● ● Rabs ● ● ● ● .... ● ● ● (for a review, see Dautry-Varsat, 2001) D. Tyteca - PhD Thesis December 4th, 2001 6

  7. chlorpromazine benzyl alcohol ➥ ➥ ➥ ➥ agents: membrane coat proteins: cytoskeleton adhesion to a budding tension and clathrin, AP curved particle asymmetry COP fission dynamin cytochalasins transport actin wortmannin gentamicin microtubules nocodazole docking fusion Rab SNARE/SNAP PI 3-kinase membrane acidification H + H + H + -ATPase phospholipi H + H + dosis chloroquine bafilomycins D. Tyteca - PhD Thesis December 4th, 2001 7

  8. limitations: ➥ ➥ ➥ ➥ almost all are unspecific and show pleiotropic effects ➥ ➥ none inhibit the earliest steps of clathrin-independent pinocytosis ➥ ➥ and azithromycin ? D. Tyteca - PhD Thesis December 4th, 2001 8

  9. Azithromycin (AZ), a dicationic amphiphile 9a CH 3 N H 3 C CH 3 9 OH OH 3' H 3 C OH CH 3 (H 3 C) 2 N H 3 C HO H 3 CH 2 C O O O CH 3 1 O O H 3 CO CH 3 CH 3 O H 3 C OH D. Tyteca - PhD Thesis December 4th, 2001 9

  10. Pharmacological properties of AZ ➥ ➥ ➥ ➥ spectrum of activity ● Gram + ● ● ● ● some Gram - ● ● ● ➥ ➥ therapeutic use ➥ ➥ ● upper and lower respiratory tract infections ● ● ● ● skin infections ● ● ● ● sexually transmitted diseases ● ● ● ● Mycobacterium avium complex in AIDS patients ● ● ● ➥ ➥ ➥ ➥ pharmacokinetic properties in vivo ● exceptionally high and rapid accumulation in tissues, and ● ● ● slow release (Foulds et al, 1990) ● consequences ● ● ● ➥ ➥ ➥ low serum concentrations ➥ ➥ ➥ ➥ ➥ decrease of the length of treatment ➥ toxicity ??? Pharmacological properties of AZ ➥ ➥ ➥ D. Tyteca - PhD Thesis December 4th, 2001 10

  11. Cellular pharmacokinetic properties of AZ ➥ accumulates in lysosomes of fibroblasts and macrophages (Carlier et al, 1994) ➥ ➥ ➥ ➥ ➥ acidotropic sequestration (de Duve et al, 1974) ➥ ➥ Extracellular Extralysosomal space fluid Lysosomes B B B H + H + H + BH + BH + BH + D. Tyteca - PhD Thesis December 4th, 2001 11

  12. Cellular toxicological properties of AZ ➥ induces a lysosomal phospholipidosis in fibroblasts (Van Bambeke et al, 1996) ➥ ➥ ➥ ➥ ➥ ➥ ➥ inhibits lysosomal phospholipase A1 (Montenez et al, 1996) D. Tyteca - PhD Thesis December 4th, 2001 12

  13. ➥ ➥ ➥ ➥ binds to negatively-charged bilayers at acidic pH (Montenez et al, 1996) ➥ ➥ ➥ ➥ perturbs the fusion of lysosomes with horseradish peroxidase (HRP)-containing endosomes (unpublished observation of Van Bambeke) D. Tyteca - PhD Thesis December 4th, 2001 13

  14. ➀ Could AZ affect earlier steps of the endocytic apparatus ? ➀ ➀ ➀ Azithromycin, a lysosomotropic antibiotic, impairs fluid-phase endocytosis in cultured fibroblasts D. Tyteca, P. Van Der Smissen, F. Van Bambeke, K. Leys, P.M. Tulkens, P.J. Courtoy & M.-P. Mingeot-Leclercq Eur. J. Cell Biol. 80: 466-478 (2001) ● Selection of experimental system ● ● ● Rat foetal fibroblasts ➥ ➥ avidly accumulate azithromycin ➥ ➥ ➥ ➥ develop lysosomal phospholipidosis ➥ ➥ ➥ ➥ ➥ ➥ extensively characterized system ● Experimental test ● ● ● Fluid-phase endocytosis D. Tyteca - PhD Thesis December 4th, 2001 14

  15. Fluid-phase endocytosis ➥ horseradish peroxidase (HRP) ➥ ➥ ➥ zipper HRP trigger non-coated coated pit (a) pit (Cupers et al, 1994) recycling compartment early phagosome (b) sorting endosome late late phagosome endosome lysosome D. Tyteca - PhD Thesis December 4th, 2001 15

  16. ● General experimental protocol ● ● ● confluent cells pretreatment with AZ (from 0 to 3 days) incubation with the endocytic tracer (from 0 to 4 h) washing, recovering and sonication assays: ➥ ➥ endocytic tracer ➥ ➥ ➥ ➥ ➥ ➥ proteins ➥ AZ ➥ ➥ ➥ ➥ ➥ ➥ phospholipids ➥ D. Tyteca - PhD Thesis December 4th, 2001 16

  17. AZ slows down fluid-phase endocytosis control cells cells pretreated with AZ D. Tyteca - PhD Thesis December 4th, 2001 17

  18. Inhibition of fluid-phase endocytosis correlates with AZ content but is independent of phospholipidosis D. Tyteca - PhD Thesis December 4th, 2001 18

  19. AZ causes a major reduction of the number of endosomes and lysosomes and impairs accessibility of HRP to swollen and overloaded endosomes/lysosomes 5 min HRP 2 h HRP CT 3 h AZ 3 days AZ D. Tyteca - PhD Thesis December 4th, 2001 19

  20. ➁ ➁ Is AZ specific to fluid-phase endocytosis ? ➁ ➁ Azithromycin inhibits clathrin-independent pinocytosis and slows down sequestration of ligand-receptor complexes into endocytic and recycling vesicles of J774 macrophages D. Tyteca, P. Van Der Smissen, M. Mettlen, F. Van Bambeke, P.M. Tulkens, M.- P. Mingeot-Leclercq & P.J. Courtoy Submitted for publication ● Selection of experimental system ● ● ● J774 mouse macrophages ➥ ➥ ➥ ➥ homogeneous cell line ➥ ➥ ➥ ➥ high endocytic activity ➥ ➥ well-characterized system for pinocytosis and phagocytosis ➥ ➥ ● Experimental tests ● ● ● ➥ ➥ ➥ ➥ fluid-phase endocytosis ➥ ➥ bulk-membrane endocytosis ➥ ➥ ➥ ➥ ➥ ➥ receptor-mediated endocytosis ➥ ➥ ➥ ➥ phagocytosis D. Tyteca - PhD Thesis December 4th, 2001 20

  21. Fluid-phase endocytosis ➥ HRP and lucifer yellow (LY) ➥ ➥ ➥ zipper HRP trigger non-coated LY coated pit (a) pit (Cupers et al, 1994; recycling Swanson et compartment al, 1987) early phagosome (b) sorting endosome late late phagosome endosome lysosome D. Tyteca - PhD Thesis December 4th, 2001 21

  22. AZ inhibits fluid-phase endocytosis and this inhibition is reversible AZ HRP LY D. Tyteca - PhD Thesis December 4th, 2001 22

  23. Bulk-membrane endocytosis ➥ ➥ N -rhodamine-phosphatidylethanolamine ( N -Rh-PE) ➥ ➥ zipper non-coated trigger coated pit (a) pit aggregates of recycling N -Rh-PE compartment early phagosome (Kok et al, 1990) sorting endosome late phagosome late endosome lysosome D. Tyteca - PhD Thesis December 4th, 2001 23

  24. 24 AZ slows down bulk-membrane endocytosis December 4th, 2001 D. Tyteca - PhD Thesis

  25. Receptor-mediated endocytosis ➥ ➥ ➥ ➥ 125 I-labelled transferrin (a) zipper Y Y Y Y Y Y Y Y Tf non-coated trigger coated pit Y TfR (b) pit Y Y Y recycling Y compartment (Cupers et al, 1994) (c) early Y Y phagosome Y Y Y Y YY sorting endosome late late phagosome endosome lysosome D. Tyteca - PhD Thesis December 4th, 2001 25

  26. AZ strongly decreases the surface-pool of transferrin receptors D. Tyteca - PhD Thesis December 4th, 2001 26

Recommend


More recommend